The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Self-citationPeginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J., Heathcote, E. J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,220
Self-citationWelt, F. G. P., & Edelman, E. R. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)90003-x · Cited by 863
Poynard, T., Leroy, V, Cohard, M., Thevenot, T., Mathurin, P., Opolon, P., & Zarski, J. P. (1996) · Hepatology · doi:10.1002/hep.510240405 · Cited by 671
Reichard, O., Norkrans, G., Frydén, A., Braconier, J.-H., Sönnerborg, A., & Weiland, O. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06088-1 · Cited by 629
Marcellin, P., Boyer, N., Gervais, A., Martinot, M., Pouteau, M., Castelnau, C., Kilani, A., Areias, J., Auperin, A., Benhamou, J. P., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00003 · Cited by 559
Natural history of hepatitis C
Seeff, L. B. (1997) · Hepatology · doi:10.1002/hep.510260704 · Cited by 409
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
Lam, N. P., Neumann, A. U., Gretch, D. R., Wiley, T. E., Perelson, A. S., & Layden, T. J. (1997) · Hepatology · doi:10.1002/hep.510260130 · Cited by 329
Self-citationThe therapeutic value of poly(ethylene glycol)-modified proteins
Nucci, M. L., Shorr, R., & Abuchowski, A. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90037-d · Cited by 276
Clinical Pharmacokinetics of Interferons
Wills, R. J. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019050-00003 · Cited by 247
Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.
McHutchison, J. G., & Poynard, T. (1999) · PubMed · Cited by 243
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
Zeuzem, S., Schmidt, J. M., Lee, J., Ruster, B., & Roth, W. K. (1996) · Hepatology · doi:10.1002/hep.510230225 · Cited by 234
Self-citationHepatitis C: global prevalence.
(1997) · PubMed · Cited by 179
Hepatitis C virus dynamics in vivo : Effect of ribavirin and interferon alfa on viral turnover
Zeuzem, S., Schmidt, J. M., Lee, J.-H., von Wagner, M., Teuber, G., & Roth, K. W. (1998) · Hepatology · doi:10.1002/hep.510280132 · Cited by 159
Self-citationDiDomenico, N., Link, H., Knobel, R., Caratsch, T., Weschler, W., Loewy, Z. G., & Rosenstraus, M. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.12.1915 · Cited by 138
Albadalejo, J., Alonso, R., Antinozzi, R., Bogard, M., Bourgault, A., Colucci, G., Fenner, T., Petersen, H., Sala, E., Vincelette, J., et al. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.862-865.1998 · Cited by 85
Self-citation
Cited by
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Lamarre, D., Anderson, P. C., Bailey, M., Beaulieu, P., Bolger, G., Bonneau, P., Bös, M., Cameron, D. R., Cartier, M., Cordingley, M. G., et al. (2003) · Nature · doi:10.1038/nature02099 · Cited by 917
Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
Mangia, A., Santoro, R., Minerva, N., Ricci, G. L., Carretta, V., Persico, M., Vinelli, F., Scotto, G., Bacca, D., Annese, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042608 · Cited by 840
Davis, G. L., Wong, J. B., McHutchison, J. G., Manns, M. P., Harvey, J., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50364 · Cited by 819
Hepatitis C virus kinetics during and immediately after liver transplantation
Garcia-Retortillo, M., Forns, X., Feliu, A., Moitinho, E., Costa, J., Navasa, M., Rimola, A., & Rodes, J. (2002) · Hepatology · doi:10.1053/jhep.2002.31773 · Cited by 503
American Gastroenterological Association Technical Review on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.010 · Cited by 384
Metadata
- Authors
- Zeuzem, S., Lee, J., Herrmann, E., Fricke, J., Neumann, A. U., Modi, M., Colucci, G., & Roth, W. K.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 120
- Issue
- 6
- Pages
- 1438-1447
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2014616917
- Cited by
- 270
- References
- 17
- FWCI
- 21.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.